<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
<journal-title-group>
<journal-title>Scientific Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2045-2322</issn>
<publisher>
<publisher-name>Nature Publishing Group UK</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30413731</article-id>
<article-id pub-id-type="pmc">6226508</article-id>
<article-id pub-id-type="publisher-id">33773</article-id>
<article-id pub-id-type="doi">10.1038/s41598-018-33773-5</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Functional eubacteria species along with trans-domain gut inhabitants favour dysgenic diversity in oxalate stone disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6054-3926</contrib-id>
<name>
<surname>Suryavanshi</surname>
<given-names>Mangesh V.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bhute</surname>
<given-names>Shrikant S.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gune</surname>
<given-names>Rahul P.</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5055-5931</contrib-id>
<name>
<surname>Shouche</surname>
<given-names>Yogesh S.</given-names>
</name>
<address>
<email>yogesh@nccs.res.in</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.419235.8</institution-id><institution>National Centre for Microbial Resource, National Centre for Cell Science, Central Tower, Sai Trinity Building Garware Circle, Sutarwadi, </institution></institution-wrap>Pashan Pune, 411021 (M.S.) India </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1767 7704</institution-id><institution-id institution-id-type="GRID">grid.413027.3</institution-id><institution>Yenepoya Reseach Centre, Yenepoya University, </institution></institution-wrap>Mangalore, 575018 (K.S.) India </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0806 6926</institution-id><institution-id institution-id-type="GRID">grid.272362.0</institution-id><institution>School of Life Sciences, University of Nevada, </institution></institution-wrap>Las Vegas, Nevada-89154 USA </aff>
<aff id="Aff4"><label>4</label>Department of Urology, RCSM Govt. Medical College, CPR Hospital Compound, Bhausingji Rd, Kolhapur, 416002 (M.S.) India </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>9</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>9</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>8</volume>
<elocation-id>16598</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Analyses across all three domains of life are necessary to advance our understanding of taxonomic dysbiosis in human diseases. In the present study, we assessed gut microbiota (eubacteria, archaea, and eukaryotes) of recurrent oxalate kidney stone suffers to explore the extent of trans-domain and functional species dysbiosis inside the gut. Trans-domain taxonomic composition, active oxalate metabolizer and butyrate-producing diversity were explored by utilizing <italic>frc-, but-</italic>, and <italic>buk-</italic> functional gene amplicon analysis. Operational taxonomic units (OTUs) level analyses confound with the observation that dysbiosis in gut microbiota is not just limited to eubacteria species, but also to other domains like archaea and eukaryotes. We found that some of healthy eubacterial population retained together with <italic>Oxalobacter formigenes</italic> and <italic>Lactobacillus plantarum</italic> colonization in disease condition (p &lt; 0.001 &amp; FDR = 0.05). Interestingly, trans-domain species diversity has been less shared and dysgenic taxa augmentation was found to be higher. Oxalate metabolizing bacterial species (OMBS) and butyrate-producing eubacteria species were found to be decreased in <italic>Oxalobacter</italic> non-colonizers; and <italic>Prevotella</italic> and <italic>Ruminococcus</italic> species which may contribute to oxalate metabolism and butyrate synthesis as well. Our study underscores fact that microbial dysbiosis is not limited to eubacteria only hence suggest the necessity of the trans-domain surveillance in metabolic diseases for intervention studies.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Microbial ecology</kwd>
<kwd>Microbial ecology</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par2">The human gut microbiome is considered as an effective metabolic organ; several host vital metabolite dependencies have been systematically incorporated and disparagingly executed within gut by it. In fact, causes and consequences of many metabolic disorders have been rationalized using high correlation with specific gut inhabitants. Dysbiosis has been usually attributed to eubacteria as previously reported in literature. Variations in the eubacterial community referred to as dysbiosis; disturbs the host health status and is found <italic>actus-reus</italic> principally in intestinal syndromes. Upon dissecting non-intestinal metabolic disorders like obesity<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>, cardiovascular disease<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> and chronic kidney disease<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>, it was understood that dysbiosis in gut eubacteria has partial verdict and indicates towards the direction for interventions in the diagnosis, treatment, and probable prevention. Most of the microbiome components have originated from the eubacteria and are diverse in genes, genomes, and their products in gut ecology<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. However, other components remain elusive regarding knowledge of their diversity and role in host health.</p>
<p id="Par3">Trans-domain gut inhabitants include eubacteria, archaea, eukaryotes and their diversity are the key players in gut ecology. Trans-domain diversity inside the human gut is not yet fully explored in healthy state as well as in impaired health condition. In some reports generated on diabetes; <italic>Methanobacter</italic> (archaea) and <italic>Aspergillus</italic> species (filamentous fungi) were found to be prevalent in the diabetic state<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.</p>
<p id="Par4">Using high throughput sequencing methods, the variations in healthy gut flora were observed and disease associated bacteria were traced universally. The persistent colonization of unique gut microflora involved in non-intestinal metabolic disorders has been correlated with host health conditions. Moreover, disease associated flora for kidney stone disease was manifested and re-enlisted specifying signature flora in canines<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>, and humans by prognosticative ways<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. The panoptic power of high throughput sequencing methods was confined to describe the species level taxonomic features of gut bacteria as it has limitations of short-read length as output. Prognosticative detection of disease associated flora is still elusive mainly due to the lack of the species-level taxonomic assignments. Apparently, defining the role of species of the gut inhabitant, along with qPCR-based species-specific detection of <italic>Oxalobacter formigenes</italic> have been indispensable in kidney stone endurers<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> and only the metagenomic sequencing approach has been found productive<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>.</p>
<p id="Par5">Functional metagenome strategy has proven to support the hypothesis related to the metabolic capacities and its diverse origin in the health status. Functional capacities of the eubacteria from the previous observations<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, gave clues about the dynamics observed in the hyperoxaluria condition due to their activities. Here, we are reporting a comprehensive catalog of functional gene diversity using functional metagenomic library. We used the functional genes such as <italic>frc-</italic>gene to decipher OMBS diversity and <italic>but-</italic> and <italic>buk-</italic>gene for butyrate-producing bacterial species (SCFA producer) diversity. Comprehensive reports on species level diversity in gut inhabitants and kidney stone associated dysbiosis in human subjects were lacking. In the present study, we focused on assessment of species-level differences between the compositions of the intestinal flora in individuals with recurrent kidney stone to that of healthy individuals based on 16S rRNA gene traditional clone libraries for the eubacteria, 18S rRNA gene for microeukaryotes and ITS region for the fungal species diversity analysis.</p>
</sec>
<sec id="Sec2" sec-type="results">
<title>Results</title>
<p id="Par6">Posited emergence of exploitation of use of the indigenous gut bacteria for recurrent episode repression was recommended<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. The colonization of <italic>Oxalobacter formigenes</italic>, a known oxalotrophic bacterium was directly linked to the disease prevalence<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. In addition to the case-control study for recurrent kidney stone disease<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, included healthy control study subjects to check whether that certain other healthy gut associated bacterial species may also dwell with the recurrent oxalate stone episodes. The comparatives in healthy subjects (HLT) and kidney stone disease subjects (KSD) (Supplementary Table <xref ref-type="media" rid="MOESM1">S1</xref>) has been explained by using amplification and sequencing of functional genes and trans-domain molecular marker genes (Table <xref ref-type="table" rid="Tab1">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Eubacterial species enriched in KSD subjects and their possible involvement in health impairments.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Bacterial species</th><th colspan="2">Explanations for Involvement in various diseases</th></tr><tr><th>Microbiota associated</th><th>Pathological detection</th></tr></thead><tbody><tr><td>
<italic>Lactobacillus mucosae</italic>
</td><td>NA</td><td>Dental caries and Dental lesions<sup><xref ref-type="bibr" rid="CR51">51</xref></sup></td></tr><tr><td>
<italic>Olsenella umbonata</italic>
</td><td>NA</td><td>Dental caries and Dental lesions<sup><xref ref-type="bibr" rid="CR52">52</xref></sup></td></tr><tr><td>
<italic>Collinsella aerofaciens</italic>
</td><td>Inflammatory Bowel Disease<sup><xref ref-type="bibr" rid="CR53">53</xref></sup></td><td>Colitogenic bacteria in inflammation<sup><xref ref-type="bibr" rid="CR54">54</xref></sup></td></tr><tr><td>
<italic>Streptococcus sanguinis</italic>
</td><td>Inflammatory Bowel Disease<sup><xref ref-type="bibr" rid="CR53">53</xref></sup></td><td>Colitogenic bacteria in inflammation<sup><xref ref-type="bibr" rid="CR54">54</xref></sup></td></tr><tr><td>
<italic>Eubacterium siraeum</italic>
</td><td>Behcet’s disease<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>, exhibit the highest affinities for Candida albicans<sup><xref ref-type="bibr" rid="CR56">56</xref></sup></td><td>Colitogenic bacteria in inflammation<sup><xref ref-type="bibr" rid="CR57">57</xref></sup></td></tr><tr><td>
<italic>Streptococcus lutetiensis</italic>
</td><td>NA</td><td>Children diarrhoea<sup><xref ref-type="bibr" rid="CR58">58</xref></sup></td></tr><tr><td>
<italic>Turicibacter sanguinis</italic>
</td><td>Children with Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and autism (AD)<sup><xref ref-type="bibr" rid="CR59">59</xref></sup></td><td>NA</td></tr><tr><td>
<italic>Veillonella dispar</italic>
</td><td>Patients with hepatitis B liver cirrhosis<sup><xref ref-type="bibr" rid="CR60">60</xref></sup></td><td>Endocarditis<sup><xref ref-type="bibr" rid="CR61">61</xref></sup></td></tr><tr><td>
<italic>Comamonas testosteroni</italic>
</td><td>NA</td><td>Bacteraemia<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>, Acute Appendicitis<sup><xref ref-type="bibr" rid="CR63">63</xref></sup></td></tr><tr><td>
<italic>Escherichia fergusonii</italic>
</td><td>NA</td><td>Bacteraemia<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>, Pneumonial pathogenesis<sup><xref ref-type="bibr" rid="CR65">65</xref></sup></td></tr><tr><td>
<italic>Klebsiella pneumoniae</italic>
</td><td>NA</td><td>Pneumonial pathogenesis<sup><xref ref-type="bibr" rid="CR66">66</xref></sup></td></tr><tr><td>
<italic>Succinivibrio dextrinosolvens</italic>
</td><td>Associated with cancer development<sup><xref ref-type="bibr" rid="CR67">67</xref></sup></td><td>NA</td></tr><tr><td>
<italic>Megamonas funiformis</italic>
</td><td>Effects on Immunity and Disease<sup><xref ref-type="bibr" rid="CR68">68</xref></sup></td><td>NA</td></tr><tr><td>
<italic>Catenibacterium mitsuokai</italic>
</td><td>Effects on Immunity and Disease<sup><xref ref-type="bibr" rid="CR68">68</xref></sup></td><td>NA</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup>NA = Not any literature found.</p></table-wrap-foot></table-wrap></p>
<sec id="Sec3">
<title>Comparison of eubacterial species and its functional diversity in HLT and KSD</title>
<p id="Par7">The oxalate metabolizing bacteria accounted for the highest at 88.13% among the enriched in KSD and found to be unique feature of oxalate kidney stone patients (KSD) (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>). The qPCR results show increased abundance of <italic>frc</italic>-gene in KSD in comparison to the HLT. However, the <italic>Oxalobacter formigenes</italic> and <italic>Lactobacillus plantarum</italic> abundance was decreased in the KSD group. We had already demonstrated the bacterial dysbiosis and enrichment of unique OMBS in subpopulation of this cohort, we reported the bacterial dysbiosis and enrichment of unique OMBS<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. We found that the colonization of <italic>Oxalobacter</italic> in the KSD subjects retains the 118 out of 785 OTUs detected (Kruskal-Wallis test, p &lt;= 0.001 &amp; FDR = 0.05), reflecting the 20.08% of HLT group flora (Supplementary File <xref ref-type="media" rid="MOESM2">S2</xref>). Such keen observation depicts that the retention of HLT microbiome could be achieved by the <italic>Oxalobacter formigenes</italic> and <italic>Lactobacillus plantarum</italic>.<fig id="Fig1"><label>Figure 1</label><caption><p>Comparatives in eubacterial colonization status of HLT and KSD subjects. (<bold>a</bold>) qPCR based quantitative estimation of <italic>Oxalobacter formigenes</italic>, total OMBS diversity (through <italic>frc-</italic>gene) and <italic>Lactobacillus plantarum</italic> in HLT and KSD (n = 72). (<bold>b</bold>) Evaluation of specific metabolism capacities of eubacteria, and respective KEGG Orthology for the enzymes involved in metabolic phenotype according to the predicted metagenome observed in HLT and KSD. (<bold>c</bold>) Heat map showing family level differences in HLT and different groups in KSD subjects. The data used to generate these graphs has been partially adopted from Suryavanshi <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p></caption><graphic id="d29e749" xlink:href="41598_2018_33773_Fig1_HTML"></graphic></fig></p>
<p id="Par8">The metagenomic imputation demonstrated the differential abundance of genes involved in oxalate metabolism in KSD (Wilcoxon sum rank test, p =&lt; 0.005) (Fig. <xref ref-type="fig" rid="Fig1">1b</xref>). We found out that certain families are characteristics of disease in the KSD subjects and in the different subjects. Certain bacterial families like Bacteriodaceae, Enterobacteraceae, and Porphyromonadaceae were found enriched and Mogibacteriaceae, Paraprevotellaceae, Alcaligenaceae, Pasterallaceae, Spirochaetaceae and Streptococcaceae were depleted in KSD (Welch’s t-test, p =&lt; 0.001 &amp; FDR = 0.05) group (Fig. <xref ref-type="fig" rid="Fig1">1c,d</xref>). As reported earlier<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>; applying the hypergeometric test function (p &lt;= 0.001), we found that such differential bacterial families are present and have their own role in KSD not by chance mechanism.</p>
<p id="Par9">In connection with functional capacities, surveillance of functional eubacteria was accessed through the <italic>frc-, but-</italic>, and <italic>buk-</italic>genes in the subpopulation (Supplementary Table <xref ref-type="media" rid="MOESM1">S3</xref>). The species level diversity of functional genes which are unique present in comparative, reported in (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Eleven bacterial species accessed through <italic>frc-</italic>gene were found to be completely absent in the KSD subpopulations in comparison to the healthy subjects. The functional gene diversity pattern of KSD was found dislodged to the HLT. Similarly, 23 bacterial species accessed through <italic>buk-</italic>gene were not found to be present in the KSD group. The functional group assessed through <italic>buk</italic>-gene revealed that only four bacterial species found in the healthy subjects diminished completely in the KSD subjects.<fig id="Fig2"><label>Figure 2</label><caption><p>Heat map showing the status of functional eubacteria in different groups in tested subjects. (<bold>a</bold>) heat map for total OMBS diversity players observed by <italic>frc-</italic>gene sequence analysis, and (<bold>b</bold>,<bold>c</bold>) reflects the Butyrate (known-SCFA) producer observed by <italic>but-</italic> and <italic>buk-</italic>gene sequence analysis respectively. Only presence-absence data represented here whereas the OMBS diversity data has been adopted from Suryavanshi <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p></caption><graphic id="d29e820" xlink:href="41598_2018_33773_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec4">
<title>Deducing the change in eubacteria species through clone library generation approach in KSD</title>
<p id="Par10">For the bacterial species diversity characterization, we obtained 16S rRNA gene clones and PCR-DGGE fingerprinting patterns of some randomly selected subjects. Total 6400 clones were randomly picked and sequenced from fourteen fecal samples from which 5057 good quality sequences of more than 750 base pairs with an average of 361 clones per sample were obtained. Measures of alpha diversity such as Cho1, Shannon and Simpson indices showed significant decrease in overall diversity in KSD subjects (Supplementary Table <xref ref-type="media" rid="MOESM1">S4</xref>). All the gut communities contained sequences from 7 bacterial phyla (Firmicutes, Bacteroidetes, Proteobacteria, Cyanobacteria, Tenericutes and Thermi). Denaturant gradient gel electrophoresis of eubacterial 16S rRNA gene revealed differential fingerprinting pattern for KSD and HLT individuals suggestive of bacterial community shift as indicated by similarity profile of DGGE band pattern for all the subjects (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>). We also analyzed the OTU abundance from each sample which corresponded to 23 different families. The bacterial families were differentially abundant in the KSD subjects (Supplementary Fig. <xref ref-type="media" rid="MOESM1">1</xref>). PCoA analysis of unweighted UniFrac distance matrix revealed distinct clustering of HLT subjects than discrete spread of KSD subjects (Fig. <xref ref-type="fig" rid="Fig3">3b</xref>). Clustering of IKF values obtained from K-Shuff revealed grouping of all HLT subjects (Fig. <xref ref-type="fig" rid="Fig3">3c</xref>).<fig id="Fig3"><label>Figure 3</label><caption><p>Compositional differences in eubacteria diversity in study subpopulations (HLT = 07 and KSD = 07). Clustering pattern of tested subpopulation through (<bold>a</bold>). PCR-DGGE fingerprint analysis in UPGMA algorithm, (<bold>b</bold>). PCoA plot and (<bold>c</bold>). IKF values on scattered plot derived from K-Shuff algorithm. (<bold>d</bold>) Species level diversity differences observed in HLT and KSD subjects, whereas shared species with significant difference (Welch’s test p &lt;= 0.05) were annotated in bubble plot.</p></caption><graphic id="d29e862" xlink:href="41598_2018_33773_Fig3_HTML"></graphic></fig></p>
<p id="Par11">We found that 833 and 90 OTUs were assigned to genus and species level identity by &gt;95.0% and &gt;97.0% of sequence identity cut off value respectively (Supplementary Table <xref ref-type="media" rid="MOESM1">S5</xref>). Out of 90 bacterial species, 33 were completely depleted and 19 were newly augmented in KSD subjects over HLT. While 12 bacterial species (p =&lt; 0.01) were found to be differentially present in KSD subjects (Fig. <xref ref-type="fig" rid="Fig3">3d</xref>). These results suggest that some bacterial species were found to be absent in the recurrent oxalate stone episodes and some new bacterial species were found to be present in such conditions. All newly augmented flora were found to be mostly aerobic and facultative <italic>Streptococcus sanguinis</italic>, <italic>Bacillus sonorensis</italic>, <italic>Comamonas testosterone</italic>, <italic>Klebsiella pneumoniae</italic> subsp. <italic>pneumoniae</italic>, <italic>Escherichia fergusonii</italic> and <italic>Veillonella denticariosi</italic>. Deserting the differential eubacteria species in KSD, most are perpetually positive in their involvement in various health impairments and sometimes may act as etiological agents (Table <xref ref-type="table" rid="Tab1">1</xref>).</p>
</sec>
<sec id="Sec5">
<title>Differences in gut inhabiting archea, eukarya and fungal species in KSD</title>
<p id="Par12">As far as the trans-domains are concerned, eubacteria along with archaea, eukaryotes and fungi are the gut inhabitants and major diversity players (Supplementary Table <xref ref-type="media" rid="MOESM1">S6</xref>). We found that the 11 members of archaea, 7 of eukarya and 6 fungal ubiquitous species of HLT group were absent in KSD subjects (Fig. <xref ref-type="fig" rid="Fig4">4</xref>). The co-occurrence pattern illustrated a comprehensive change in the microbial community of the KSD subjects in comparison to the healthy individuals (Fig. <xref ref-type="fig" rid="Fig5">5</xref>).<fig id="Fig4"><label>Figure 4</label><caption><p>Trans-domain species diversity present in 5 groups (<bold>a</bold>) Diagrammatic illustration of unique Trans-domain species in each group, whereas comparison in HLT and KSD subjects only. The color of petal indicates the number of unique species either in HLT or KSD subject within 5 group. (<bold>b</bold>–<bold>d</bold>) Heatmap showing the species diversity in each five groups with pink (archaea), green (microeukaryotes) and violet (fungi) represents actual trans-domain components. Diversity was studied by the conserved genes such as 16S rRNA gene (archaea and eubacteria), 18S rRNA gene (microeukaryotes) and ITS region (fungi) sequencing. Presence and absence of gene bearing species data utilized for the representation.</p></caption><graphic id="d29e927" xlink:href="41598_2018_33773_Fig4_HTML"></graphic></fig><fig id="Fig5"><label>Figure 5</label><caption><p>Diagrammatic illustration of Trans-domain species found in the tested subjects. An overall number of Trans-domain species (eubacteria, archaea, fungi, and microeukaryotes) in HLT and KSD subjects were demonstrated and presented only on presence or absence data through igraph. The Tran-domain species which were uniquely distributed in either HLT or KSD subjects are represented by red (HLT), blue (KSD) and violet color for common species.</p></caption><graphic id="d29e936" xlink:href="41598_2018_33773_Fig5_HTML"></graphic></fig></p>
</sec>
</sec>
<sec id="Sec6" sec-type="discussion">
<title>Discussion</title>
<p id="Par13">Kidney stones are believed to be multi-factorial diseases and are predominantly found in male than in female<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Although, the oxalate stones in urinary system are perceived as a part of hyperoxaluria in many individuals may with recurrent episodes, and sometimes leading to chronic disease<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. In last two decades, satisfactory regime for diagnosis and treatment of recurrent kidney stones focused on the factors affecting handling of oxalate by the intestine as a part of homeostasis driven by the host<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> and rather the structure and composition of gut microbial communities inside the gut<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. Dysbiosis associated with pathogenesis of the kidney and the large intestine microbiome would be the bi-directional operative axis for its proper functioning. In connection with altered microflora with respect to chronic kidney disease<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup>, the specific reports on alteration in gut microbiome associated with kidney stones of human subjects and their metabolic potentials are little scanty. We present this study as an attempt to elucidate the changes in the trans-domain microbial species including eubacteria, archaea, fungi and micro-eukaryotes, and their function in lieu of kidney stone disease.</p>
<sec id="Sec7">
<title>Eubacterial family and their functional alterations are characteristics of oxalate stone disease</title>
<p id="Par14">Oxalate influences the colonic microbial metabolism whereas; microbial-related metabolites are speculated to be involved in the progression of the kidney disease. In the present study, we applied two culture-independent approaches namely 16S rRNA clone library and PCR-DGGE to reveal bacterial community structure of gut flora in KSD subjects. Qualitative and quantitation perturbations in functional eubacteria species also were found.</p>
<p id="Par15">Major players like <italic>Oxalobacter formigenes</italic> and <italic>Lactobacillus plantarum</italic> species are the key eubacteria in Indian healthy gut and their quantitative values provides the reference material in colonization status even in oxalate kidney stone disease. <italic>Lactobacillus plantarum</italic> species has been reported from the healthy gut flora in the same population<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>, and here we found out negative correlation with hyperoxaluria condition even high with their oxalate tolerance capacity evaluated previously.</p>
<p id="Par16">From clustering pattern based on PCR-DGGE and PCoA plot based on unweighted UniFrac we observed that KSD subjects are dispersed as compared to HLT subjects. We speculate that this may be due to more different OTU composition of KSD than HLT and among them. Inter-individual difference among the KSD subjects could be because of recurrent episodes of kidney stones and different number of stones.</p>
<p id="Par17">Our findings on human subjects showing increased abundance of Firmicutes and decreased abundance of Bacteroidetes are in agreement with the previous studies relating to the gut microflora and the oxalate stones in humans<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup> and even in the dogs<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. However, at the genus level various distinctions are observed confirming the fact that the gut microbiota varies according to the host type<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. We observed dominance of genera such as <italic>Collinsella</italic> and reduction in genera like <italic>Bacteroides</italic>, <italic>Deinococcus and Sutterella</italic> in KSD group. <italic>Collinsella</italic> is known to be involved in deconjugation of bile acids<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and is also associated with disease like symptomatic atherosclerosis<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>. Thus, high abundance of <italic>Collinsella</italic> in the gut microbiota may be an indicator of a disturbed gut. Bacterial phylotypes of <italic>Bacteroides</italic> genera are potentially involved in glycan synthesis<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Highly robust bacteria such as <italic>Deinococcus</italic> have been shown to be adapted for human gut colonization<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> and members of <italic>Sutterella</italic> have been found to be linked with autism disease in children<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>.</p>
<p id="Par18">The change in the gut microbial community structure of KSD patients in comparison with the healthy subjects could be attributed to the diet patterns. Strict dietary restrictions in advanced CKD for high-fiber products could affect the makeup and/or metabolism of the gut flora<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>.</p>
</sec>
<sec id="Sec8">
<title>Alterations are dislodged to the functional eubacteria species diversity</title>
<p id="Par19">On the other hand, species level dysbiosis was found in disease conditions whereas, certain bacterial species which were involved in other diseases were augmented. Lactic acid fermenting-mucosa associated bacteria, <italic>Olsenella umbonata</italic> has ability to produce 4-methylphenol (p-cresol) from p-hydroxyphenylacetic acid<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Absolute findings of novel bacterial species in human gut are leading towards greater exploration of gut microflora then we have ever speculated<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Some of species like <italic>Eubacterium siraeum</italic> has been reported for biosynthesis of conjugated linoleic acid<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> and <italic>Klebsiella pneumoniae</italic> have a phospholipase D family protein as a novel virulence factor<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>.</p>
<p id="Par20">For reduction in glycans and complex carbohydrates helping bacteria were depleted <italic>Bacteroides plebeius</italic><sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. Propionate production within the human gut microbiota was reported including <italic>Dialister succinatiphilus</italic><sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. <italic>Eubacterium eligens</italic> has known for dietary fibers production by pectin<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Downshift pH 5.5 resulted in <italic>Faecalibacterium prausnitzii</italic> lowering and underlying atopic dermatitis<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Variety of carbohydrates including the inulin, pectin can be metabolized by <italic>Faecalibacterium</italic> and have efficient processing ability of D-glucosamine and N-acetyl-d-glucosamine<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>. <italic>Faecalibacterium prausnitzii</italic> is known anti-inflammatory commensal flora<sup><xref ref-type="bibr" rid="CR37">37</xref></sup> which have the ability to grow at oxic–anoxic interphases<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>. This fact suggests that either hyperoxaluric condition may be responsible for enrichment of some oxalate utilizing bacterial genera that are not observed in healthy subjects; or due to the disturbed microflora inside the gut may impart the hyperoxaluric condition to the host are still unclear.</p>
<p id="Par21">Our PICRUSt analysis revealed several important findings of gut microbiome in relation to calcium oxalate stone formation. Inositol, which is also known as phytate seems to have important role in preventing calcium oxalate stone formation. Levels of inositol was found to be significantly reduced in people with calcium oxalate stone formers<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> and in rat models phytate has been shown to have inhibitory role on deposition of calcium oxalate stones<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. Previous study has shown dissolution effect of lysine on calcium oxalate by considerably lowering the super-saturation of the urine<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Similarly, there are reports showing reduced levels of tyrosine in stone formers compared to control subjects<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. Interestingly, our results showed significant degradation of lysine and metabolism of tyrosine by gut microbiota in KSD subjects suggesting that effective concentration of lysine and tyrosine needed for dissolution of calcium oxalate stones was never attained in these subjects, thus chances of recurrent stone formation are increased in these subjects. We observed that gut microbiota of KSD subjects was dominant with gene families involved in fatty acid synthesis. Fatty acid and bile acid malabsorption is a one of the risk factors for hyperoxaluria in mal-absorptive patients and low fat diet is often advocated to these patients to prevent hyperoxaluria<sup><xref ref-type="bibr" rid="CR43">43</xref></sup>.</p>
</sec>
<sec id="Sec9">
<title>Trans-Domain gut inhabitants favor the dysgenic diversity in oxalate disease</title>
<p id="Par22">In the human gut diverse prokaryotic populations have been studied well compared with that of the eukaryotic fraction which are still underway<sup><xref ref-type="bibr" rid="CR29">29</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>. The current studies on the gut resident microbial eukaryotes give clues for either beneficial or commensal. Elucidating such crucial piece of gut community to cause of several diseases might be potential treatment factor cannot be denied.</p>
<p id="Par23">Although the methanogens, species like <italic>Methanobrevibacter smithii</italic> and <italic>Methanosphaera stadtmanae</italic> have the most dominant archaeal groups inside the human gut<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>. The two fungal phyla Ascomycota (which includes the genera <italic>Candida</italic> and <italic>Saccharomyces</italic>) and Basidiomycota are the prominent fungal diversity<sup><xref ref-type="bibr" rid="CR47">47</xref>,<xref ref-type="bibr" rid="CR48">48</xref></sup>. Our observation is also in agreement with the archaeal and fungal diversity in Indian population. Previous reports have indicated that dysbiosis in the fungal population of the human gut can be associated with intestinal disease and infections. In the present study, there is an evident change in the eukaryotic, archaeal and fungal populations in KSD patients as compared with healthy individuals. The results suggest that the selection pressure on the part of the host and the microbes shapes the structure, composition, and function of not only the bacterial populations but also the trans-domain diversity. However, this is the first report indicating a direct correlation between the kidney stone disease and altered diversity of gut microflora involving archaeal and fungal participants. Despite maintaining of an ecosystem the colonization of <italic>Oxalobacter formigenes</italic> inside the human gut as healthy gut flora<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> describing the withholds host health features and other core microbiome as well<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. As their absence corresponds to enhanced level of oxalate in systemic fluid<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>, replacement therapy granted the recovery from hyperoxaluria condition in humans<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Demonstrating the colonization status of <italic>Oxalobacter formigenes</italic>, we speculate the major role of this bacterium in settlement of functional eubacteria and trans-domain species as well as in symptomatic phase of hyperoxaluria i.e. oxalate stone disease (Fig. <xref ref-type="fig" rid="Fig6">6</xref>). Presence of <italic>Oxalobacter formigenes</italic> has positively impacted on <italic>Lactobacillus plantarum</italic>, known butyrate producers and Bacteriodetes members’ colonization and inversely related to <italic>Methanobrevibacter smithii</italic>, filamentous fungi and Fermicutes members’ in this Indian population study.<fig id="Fig6"><label>Figure 6</label><caption><p>Diagrammatic illustration of actual observations in all tested subjects. Eubacterial species diversity and functional diversity was depicted using amplicon sequencing and qPCR assays. Other Trans-domain diversity was depicted using amplicon sequencing based analysis only. Arrow indicates the abundance level of trans-domain components in disease state.</p></caption><graphic id="d29e1241" xlink:href="41598_2018_33773_Fig6_HTML"></graphic></fig></p>
<p id="Par24">In conclusion, our study reports that the dysbiosis of gut microbial communities in recurrent oxalate kidney stone sufferers are limited not just to structural but also to the active functional players. Even though our study was limited to small number of participants; the results highlight the vast diversity of oxalate metabolizing bacteria in the human gut. Metabolic features, immunological response panel and disturbed trans-domain species correlation may give a definitive picture of hyperoxaluria condition. We hope our study would provide basic clues for high throughput DNA sequencing studies linking the role of gut microbiota and more information on trans-domain species in the development of oxalate kidney stones. Subsequently it helps to formulate the microbiome based biomarkers for its recurrent episodes.</p>
</sec>
</sec>
<sec id="Sec10" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="Sec11">
<title>Study samples and data generation</title>
<p id="Par25">Inclusion of all the recruited subjects was based on the National Centre for Cell Science’s institutional ethics committee’s approval; in accordance with declaration of Helsinki principles. A total of seventy-two subjects were enrolled with their separate written informed consent form; symptomatic kidney stone diseased (n = 24) hereafter referred to as KSD, and Healthy control (n = 48) hereafter called HLT were involved in the present study. Subpopulations from this cohort had been already explained elsewhere as a case-control study<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Sample collection, processing, amplicon- and functional- metagenomic data generation with subsequent analysis has been explained in Supplementary File <xref ref-type="media" rid="MOESM3">S7</xref>.</p>
</sec>
<sec id="Sec12">
<title>Raw sequence deposition</title>
<p id="Par26">Eubacterial clone library sequences were deposited at NCBI GenBank with accession numbers KF229803-KF233412 and KF864681-KF866127. Raw sequences generated through Ion Torrent PGM in the present study including <italic>frc-, but-</italic>,and <italic>buk-</italic>gene as functional genes and Archaeal 16S rRNA gene, microeukaryotic 18S rRNA gene and fungal ITS region as trans-domain gene amplicons were deposited to SRA-NCBI under accession number SRP067039.</p>
</sec>
</sec>
<sec sec-type="supplementary-material">
<title>Electronic supplementary material</title>
<sec id="Sec13">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2018_33773_MOESM1_ESM.pdf"><caption><p>Supplementary Tables</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41598_2018_33773_MOESM2_ESM.xlsx"><caption><p>Supplementary File S2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41598_2018_33773_MOESM3_ESM.doc"><caption><p>Supplementary File S7</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<fn-group>
<fn>
<p><bold>Publisher’s note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>
<bold>Change history</bold>
</p>
<p>5/23/2019</p>
<p>A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.</p>
</fn>
</fn-group>
<sec>
<title>Electronic supplementary material</title>
<p><bold>Supplementary information</bold> accompanies this paper at 10.1038/s41598-018-33773-5.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>MS and SB acknowledge Council of Scientific and Industrial research (CSIR-SRF) and University Grant Commission (UGC-SRF) respectively for the research fellowships for PhD thesis work. Authors are thankful to the Department of Biotechnology (DBT), Government of India; Microbial Culture Collection Project (BT/PR10054/NDB/52/94/2007) for financial aids. Authors are thankful to Dr. Shashi Ghodake, DDS, Middletown, CT 06457, USA for proofreading of the manuscript.</p>
</ack>
<notes notes-type="author-contribution">
<title>Author Contributions</title>
<p>M.S., S.B., R.G. and Y.S. were involved in the study design; M.S., and R.G. were involved in the sample collection; M.S., S.B. and Y.S. were involved in the experimental work; M.S. and S.B. were involved in the bioinformatics and statistical analysis, and interpretation of the data; M.S. and S.B. were involved in the drafting of the manuscript; S.B., R.G. and Y.S. were involved in the critical revision of the manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<title>Competing Interests</title>
<p id="Par27">The authors declare no competing interests.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>PJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title>
<source/>Nature
          <year>2006</year>
<volume>444</volume>
<fpage>1027</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1038/nature05414</pub-id>
<pub-id pub-id-type="pmid">17183312</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease</article-title>
<source/>Nature
          <year>2011</year>
<volume>472</volume>
<fpage>57</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1038/nature09922</pub-id>
<pub-id pub-id-type="pmid">21475195</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaziri</surname>
<given-names>ND</given-names>
</name>
</person-group>
<article-title>CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity</article-title>
<source/>Curr. Opin. Nephrol. Hypertens.
          <year>2012</year>
<volume>21</volume>
<fpage>587</fpage>
<lpage>92</lpage>
<pub-id pub-id-type="doi">10.1097/MNH.0b013e328358c8d5</pub-id>
<pub-id pub-id-type="pmid">23010760</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<mixed-citation publication-type="other">Human Microbiome Project Consortium, T. Structure, function and diversity of the healthy human microbiome. <italic>Nature</italic><bold>486</bold>, 207–14 (2012).</mixed-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<mixed-citation publication-type="other">Bhute, S. S. <italic>et al</italic>. Gut microbial diversity assessment of Indian type-2-diabetics reveals alterations in eubacteria, archaea, and eukaryotes. <italic>Front. Microbiol</italic>. <bold>8</bold>, 10.3389/fmicb.2017.00214 (2017).</mixed-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gnanandarajah</surname>
<given-names>JS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comparative faecal microbiota of dogs with and without calcium oxalate stones</article-title>
<source/>Ournal Am. Med. Assoc.
          <year>2012</year>
<volume>113</volume>
<fpage>745</fpage>
<lpage>56</lpage>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stern</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers</article-title>
<source/>Urolithiasis
          <year>2016</year>
<volume>44</volume>
<fpage>399</fpage>
<lpage>407</lpage>
<pub-id pub-id-type="doi">10.1007/s00240-016-0882-9</pub-id>
<pub-id pub-id-type="pmid">27115405</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siener</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of <italic>Oxalobacter formigenes</italic> colonization in calcium oxalate stone disease</article-title>
<source/>Kidney Int.
          <year>2013</year>
<volume>83</volume>
<fpage>1144</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1038/ki.2013.104</pub-id>
<pub-id pub-id-type="pmid">23536130</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title><italic>Oxalobacter formigenes</italic>-associated host features and microbial community structures examined using the American Gut Project</article-title>
<source/>Microbiome
          <year>2017</year>
<volume>5</volume>
<fpage>108</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-017-0316-0</pub-id>
<pub-id pub-id-type="pmid">28841836</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnett</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nazzal</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Goldfarb</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Blaser</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>The Presence of <italic>Oxalobacter formigenes</italic> in the Microbiome of Healthy Young Adults</article-title>
<source/>J. Urol.
          <year>2016</year>
<volume>195</volume>
<fpage>499</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1016/j.juro.2015.08.070</pub-id>
<pub-id pub-id-type="pmid">26292041</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suryavanshi</surname>
<given-names>MV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures</article-title>
<source/>Sci. Rep.
          <year>2016</year>
<volume>6</volume>
<fpage>34712</fpage>
<pub-id pub-id-type="doi">10.1038/srep34712</pub-id>
<pub-id pub-id-type="pmid">27708409</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoppe</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Efficacy and safety of <italic>Oxalobacter formigenes</italic> to reduce urinary oxalate in primary hyperoxaluria</article-title>
<source/>Nephrol. Dial. Transplant.
          <year>2011</year>
<volume>26</volume>
<fpage>3609</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1093/ndt/gfr107</pub-id>
<pub-id pub-id-type="pmid">21460356</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expansion of Urease- and Uricase-Containing, Indole- and p-Cresol-Forming and Contraction of Short-Chain Fatty Acid-Producing Intestinal Microbiota in ESRD</article-title>
<source/>Am. J. Nephrol.
          <year>2014</year>
<volume>39</volume>
<fpage>230</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1159/000360010</pub-id>
<pub-id pub-id-type="pmid">24643131</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daudon</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Doré</surname>
<given-names>J-C</given-names>
</name>
<name>
<surname>Jungers</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lacour</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Changes in stone composition according to age and gender of patients: a multivariate epidemiological approach</article-title>
<source/>Urol. Res.
          <year>2004</year>
<volume>32</volume>
<fpage>241</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1007/s00240-004-0421-y</pub-id>
<pub-id pub-id-type="pmid">15127165</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cochat</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rumsby</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Primary hyperoxaluria</article-title>
<source/>N. Engl. J. Med.
          <year>2013</year>
<volume>369</volume>
<fpage>649</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMra1301564</pub-id>
<pub-id pub-id-type="pmid">23944302</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asplin</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Hyperoxaluric calcium nephrolithiasis</article-title>
<source/>Endocrinol. Metab. Clin. North Am.
          <year>2002</year>
<volume>31</volume>
<fpage>927</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1016/S0889-8529(02)00030-0</pub-id>
<pub-id pub-id-type="pmid">12474639</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robijn</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hoppe</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Vervaet</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>D’Haese</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Verhulst</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Hyperoxaluria: a gut-kidney axis?</article-title>
<source/>Kidney Int.
          <year>2011</year>
<volume>80</volume>
<fpage>1146</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1038/ki.2011.287</pub-id>
<pub-id pub-id-type="pmid">21866092</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramezani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>DS</given-names>
</name>
</person-group>
<article-title>The gut microbiome, kidney disease, and targeted interventions</article-title>
<source/>J. Am. Soc. Nephrol.
          <year>2014</year>
<volume>25</volume>
<fpage>657</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2013080905</pub-id>
<pub-id pub-id-type="pmid">24231662</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vaziri</surname>
<given-names>ND</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chronic kidney disease alters intestinal microbial flora</article-title>
<source/>Kidney Int.
          <year>2013</year>
<volume>83</volume>
<fpage>308</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1038/ki.2012.345</pub-id>
<pub-id pub-id-type="pmid">22992469</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suryavanshi</surname>
<given-names>MV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Draft genome sequence of <italic>Lactobacillus plantarum</italic> strains E2C2 and E2C5 isolated from human stool culture</article-title>
<source/>Stand. Genomic Sci.
          <year>2017</year>
<volume>12</volume>
<fpage>15</fpage>
<pub-id pub-id-type="doi">10.1186/s40793-017-0222-x</pub-id>
<pub-id pub-id-type="pmid">28163824</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>16S rRNA gene sequencing reveals altered composition of gut microbiota in individuals with kidney stones</article-title>
<source/>Urolithiasis
          <year>2018</year>
<pub-id pub-id-type="doi">10.1007/s00240-018-1037-y</pub-id>
<pub-id pub-id-type="pmid">30488093</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muegge</surname>
<given-names>BD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans</article-title>
<source/>Science
          <year>2011</year>
<volume>332</volume>
<fpage>970</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1126/science.1198719</pub-id>
<pub-id pub-id-type="pmid">21596990</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lahti</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Associations between the human intestinal microbiota, <italic>Lactobacillus rhamnosus</italic> GG and serum lipids indicated by integrated analysis of high-throughput profiling data</article-title>
<source/>PeerJ
          <year>2013</year>
<volume>1</volume>
<fpage>e32</fpage>
<pub-id pub-id-type="doi">10.7717/peerj.32</pub-id>
<pub-id pub-id-type="pmid">23638368</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karlsson</surname>
<given-names>FH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Symptomatic atherosclerosis is associated with an altered gut metagenome</article-title>
<source/>Nat. Commun.
          <year>2012</year>
<volume>3</volume>
<fpage>1245</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms2266</pub-id>
<pub-id pub-id-type="pmid">23212374</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coyne</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Reinap</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Comstock</surname>
<given-names>LE</given-names>
</name>
</person-group>
<article-title>Human symbionts use a host-like pathway for surface fucosylation</article-title>
<source/>Science
          <year>2005</year>
<volume>307</volume>
<fpage>1778</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1126/science.1106469</pub-id>
<pub-id pub-id-type="pmid">15774760</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>H-P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Spatial heterogeneity of gut microbiota reveals multiple bacterial communities with distinct characteristics</article-title>
<source/>Sci. Rep.
          <year>2014</year>
<volume>4</volume>
<fpage>6185</fpage>
<pub-id pub-id-type="doi">10.1038/srep06185</pub-id>
<pub-id pub-id-type="pmid">25155166</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<mixed-citation publication-type="other">Williams, B. L., Hornig, M., Parekh, T. &amp; Lipkin, W. I. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of <italic>Sutterella</italic> species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. <italic>MBio</italic><bold>3</bold>10.1128/mBio.00261-11 (2012).</mixed-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Højberg</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Canibe</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title><italic>Olsenella scatoligenes</italic> sp. nov., a 3-methylindole-(skatole) and 4-methylphenol-(p-cresol) producing bacterium isolated from pig faeces</article-title>
<source/>Int. J. Syst. Evol. Microbiol.
          <year>2015</year>
<volume>65</volume>
<fpage>1227</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1099/ijs.0.000083</pub-id>
<pub-id pub-id-type="pmid">25634945</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suau</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut</article-title>
<source/>Appl. Environ. Microbiol.
          <year>1999</year>
<volume>65</volume>
<fpage>4799</fpage>
<lpage>807</lpage>
<pub-id pub-id-type="pmid">10543789</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Devillard</surname>
<given-names>E</given-names>
</name>
<name>
<surname>McIntosh</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Wallace</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Metabolism of linoleic acid by human gut bacteria: different routes for biosynthesis of conjugated linoleic acid</article-title>
<source/>J. Bacteriol.
          <year>2007</year>
<volume>189</volume>
<fpage>2566</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.1128/JB.01359-06</pub-id>
<pub-id pub-id-type="pmid">17209019</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lery</surname>
<given-names>LMS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Comparative analysis of <italic>Klebsiella pneumoniae</italic> genomes identifies a phospholipase D family protein as a novel virulence factor</article-title>
<source/>BMC Biol.
          <year>2014</year>
<volume>12</volume>
<fpage>41</fpage>
<pub-id pub-id-type="doi">10.1186/1741-7007-12-41</pub-id>
<pub-id pub-id-type="pmid">24885329</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hehemann</surname>
<given-names>J-H</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Pudlo</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Martens</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Boraston</surname>
<given-names>AB</given-names>
</name>
</person-group>
<article-title>Bacteria of the human gut microbiome catabolize red seaweed glycans with carbohydrate-active enzyme updates from extrinsic microbes</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2012</year>
<volume>109</volume>
<fpage>19786</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1211002109</pub-id>
<pub-id pub-id-type="pmid">23150581</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reichardt</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phylogenetic distribution of three pathways for propionate production within the human gut microbiota</article-title>
<source/>ISME J.
          <year>2014</year>
<volume>8</volume>
<fpage>1323</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1038/ismej.2014.14</pub-id>
<pub-id pub-id-type="pmid">24553467</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chung</surname>
<given-names>WSF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Modulation of the human gut microbiota by dietary fibres occurs at the species level</article-title>
<source/>BMC Biol.
          <year>2016</year>
<volume>14</volume>
<fpage>3</fpage>
<pub-id pub-id-type="doi">10.1186/s12915-015-0224-3</pub-id>
<pub-id pub-id-type="pmid">26754945</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yoo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Na</surname>
<given-names>Y-C</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HS</given-names>
</name>
</person-group>
<article-title><italic>Faecalibacterium prausnitzii</italic> subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis</article-title>
<source/>J. Allergy Clin. Immunol.
          <year>2016</year>
<volume>137</volume>
<fpage>852</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaci.2015.08.021</pub-id>
<pub-id pub-id-type="pmid">26431583</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinken</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional metabolic map of <italic>Faecalibacterium prausnitzii</italic>, a beneficial human gut microbe</article-title>
<source/>J. Bacteriol.
          <year>2014</year>
<volume>196</volume>
<fpage>3289</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="doi">10.1128/JB.01780-14</pub-id>
<pub-id pub-id-type="pmid">25002542</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sokol</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2008</year>
<volume>105</volume>
<fpage>16731</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0804812105</pub-id>
<pub-id pub-id-type="pmid">18936492</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>MT</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut anaerobe <italic>Faecalibacterium prausnitzii</italic> uses an extracellular electron shuttle to grow at oxic-anoxic interphases</article-title>
<source/>ISME J.
          <year>2012</year>
<volume>6</volume>
<fpage>1578</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1038/ismej.2012.5</pub-id>
<pub-id pub-id-type="pmid">22357539</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grases</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Urinary phytate in calcium oxalate stone formers and healthy people-dietary effects on phytate excretion</article-title>
<source/>Scand. J. Urol. Nephrol.
          <year>2000</year>
<volume>34</volume>
<fpage>162</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1080/003655900750016526</pub-id>
<pub-id pub-id-type="pmid">10961468</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grases</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Phytate acts as an inhibitor in formation of renal calculi</article-title>
<source/>Front. Biosci.
          <year>2007</year>
<volume>12</volume>
<fpage>2580</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.2741/2256</pub-id>
<pub-id pub-id-type="pmid">17127264</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atanassova</surname>
<given-names>SS</given-names>
</name>
</person-group>
<article-title>Influence of the lysine on the calcium oxalate renal calculi</article-title>
<source/>Int. Urol. Nephrol.
          <year>2014</year>
<volume>46</volume>
<fpage>593</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1007/s11255-013-0532-x</pub-id>
<pub-id pub-id-type="pmid">24057683</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atanassova</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Panchev</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ivanova</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Plasma levels and urinary excretion of amino acids by subjects with renal calculi</article-title>
<source/>Amino Acids
          <year>2010</year>
<volume>38</volume>
<fpage>1277</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1007/s00726-009-0359-z</pub-id>
<pub-id pub-id-type="pmid">19787430</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bosaeus</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Hyperoxaluria in malabsorptive states</article-title>
<source/>Urol. Int.
          <year>1981</year>
<volume>36</volume>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1159/000280387</pub-id>
<pub-id pub-id-type="pmid">7020204</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckburg</surname>
<given-names>PB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diversity of the human intestinal microbial flora</article-title>
<source/>Science
          <year>2005</year>
<volume>308</volume>
<fpage>1635</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1126/science.1110591</pub-id>
<pub-id pub-id-type="pmid">15831718</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gill</surname>
<given-names>SR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Metagenomic Analysis of the Human Distal Gut Microbiome</article-title>
<source/>Science
          <year>2006</year>
<volume>312</volume>
<fpage>1355</fpage>
<lpage>1359</lpage>
<pub-id pub-id-type="doi">10.1126/science.1124234</pub-id>
<pub-id pub-id-type="pmid">16741115</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mihajlovski</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Alric</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brugère</surname>
<given-names>J-F</given-names>
</name>
</person-group>
<article-title>A putative new order of methanogenic Archaea inhabiting the human gut, as revealed by molecular analyses of the mcrA gene</article-title>
<source/>Res. Microbiol.
          <year>2008</year>
<volume>159</volume>
<fpage>516</fpage>
<lpage>521</lpage>
<pub-id pub-id-type="doi">10.1016/j.resmic.2008.06.007</pub-id>
<pub-id pub-id-type="pmid">18644435</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ott</surname>
<given-names>SJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fungi and inflammatory bowel diseases: Alterations of composition and diversity</article-title>
<source/>Scand. J. Gastroenterol.
          <year>2008</year>
<volume>43</volume>
<fpage>831</fpage>
<lpage>841</lpage>
<pub-id pub-id-type="doi">10.1080/00365520801935434</pub-id>
<pub-id pub-id-type="pmid">18584522</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scanlan</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Marchesi</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces</article-title>
<source/>ISME J.
          <year>2008</year>
<volume>2</volume>
<fpage>1183</fpage>
<lpage>1193</lpage>
<pub-id pub-id-type="doi">10.1038/ismej.2008.76</pub-id>
<pub-id pub-id-type="pmid">18670396</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gulhan</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Relationship between Serum Oxalic Acid, Central Hemodynamic Parameters and Colonization by <italic>Oxalobacter formigenes</italic> in Hemodialysis Patients</article-title>
<source/>Cardiorenal Med.
          <year>2015</year>
<volume>5</volume>
<fpage>164</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="doi">10.1159/000381219</pub-id>
<pub-id pub-id-type="pmid">26195968</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Milliner</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hoppe</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Groothoff</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria</article-title>
<source/>Urolithiasis
          <year>2018</year>
<volume>46</volume>
<fpage>313</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1007/s00240-017-0998-6</pub-id>
<pub-id pub-id-type="pmid">28718073</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of Lactobacillus from the saliva of adult patients with caries using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<fpage>e106185</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0106185</pub-id>
<pub-id pub-id-type="pmid">25166027</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obata</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of the microbiota in carious dentin lesions using 16S rRNA gene sequencing</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<fpage>e103712</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0103712</pub-id>
<pub-id pub-id-type="pmid">25083880</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palm</surname>
<given-names>NW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Immunoglobulin A Coating Identifies Colitogenic Bacteria in Inflammatory Bowel Disease</article-title>
<source/>Cell
          <year>2014</year>
<volume>158</volume>
<fpage>1000</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.08.006</pub-id>
<pub-id pub-id-type="pmid">25171403</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hakansson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Molin</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Gut microbiota and inflammation</article-title>
<source/>Nutrients
          <year>2011</year>
<volume>3</volume>
<fpage>637</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="doi">10.3390/nu3060637</pub-id>
<pub-id pub-id-type="pmid">22254115</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshikawa</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cloning and sequencing of BeS-1 gene encoding the immunogenic antigen of Streptococcus sanguis KTH-1 isolated from the patients with Behçet’s disease</article-title>
<source/>Zentralblatt für Bakteriol. Int. J. Med. Microbiol.
          <year>1998</year>
<volume>287</volume>
<fpage>449</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/S0934-8840(98)80184-9</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Jabra-Rizk</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>O’May</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>William Costerton</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shirtliff</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Polymicrobial interactions: Impact on pathogenesis and human disease</article-title>
<source/>Clin. Microbiol. Rev.
          <year>2012</year>
<volume>25</volume>
<fpage>193</fpage>
<lpage>213</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.00013-11</pub-id>
<pub-id pub-id-type="pmid">22232376</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kraal</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Abubucker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kota</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fischbach</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Mitreva</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The prevalence of species and strains in the human microbiome: a resource for experimental efforts</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<fpage>e97279</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0097279</pub-id>
<pub-id pub-id-type="pmid">24827833</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dynamics of fecal microbial communities in children with diarrhea of unknown etiology and genomic analysis of associated <italic>Streptococcus lutetiensis</italic></article-title>
<source/>BMC Microbiol.
          <year>2013</year>
<volume>13</volume>
<fpage>141</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2180-13-141</pub-id>
<pub-id pub-id-type="pmid">23782707</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Angelis</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified</article-title>
<source/>PLoS One
          <year>2013</year>
<volume>8</volume>
<fpage>e76993</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0076993</pub-id>
<pub-id pub-id-type="pmid">24130822</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach</article-title>
<source/>BMC Gastroenterol.
          <year>2013</year>
<volume>13</volume>
<fpage>175</fpage>
<pub-id pub-id-type="doi">10.1186/1471-230X-13-175</pub-id>
<pub-id pub-id-type="pmid">24369878</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loughrey</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Chew</surname>
<given-names>EW</given-names>
</name>
</person-group>
<article-title>Endocarditis caused by <italic>Veillonella dispar</italic></article-title>
<source/>J. Infect.
          <year>1990</year>
<volume>21</volume>
<fpage>319</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1016/0163-4453(90)94197-8</pub-id>
<pub-id pub-id-type="pmid">2273279</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farshad</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Norouzi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aminshahidi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Heidari</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Alborzi</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Two cases of bacteremia due to an unusual pathogen, <italic>Comamonas testosteroni</italic> in Iran and a review literature</article-title>
<source/>J. Infect. Dev. Ctries.
          <year>2012</year>
<volume>6</volume>
<fpage>521</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="pmid">22706196</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bayhan</surname>
<given-names>Gİ</given-names>
</name>
<name>
<surname>Tanır</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Karaman</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Ozkan</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title><italic>Comamonas testosteroni</italic>: An Unusual Bacteria Associated with Acute Appendicitis</article-title>
<source/>Balkan Med. J.
          <year>2013</year>
<volume>30</volume>
<fpage>447</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.5152/balkanmedj.2013.9135</pub-id>
<pub-id pub-id-type="pmid">25207159</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahapatra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mahapatra</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title><italic>Escherichia fergusonii</italic>: An emerging pathogen in South Orissa</article-title>
<source/>Indian J. Med. Microbiol.
          <year>2005</year>
<volume>23</volume>
<fpage>204</fpage>
<pub-id pub-id-type="doi">10.4103/0255-0857.16598</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaastra</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kusters</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>van Duijkeren</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lipman</surname>
<given-names>LJA</given-names>
</name>
</person-group>
<article-title>
<italic>Escherichia fergusonii</italic>
</article-title>
<source/>Veterinary Microbiology
          <year>2014</year>
<volume>172</volume>
<fpage>7</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/j.vetmic.2014.04.016</pub-id>
<pub-id pub-id-type="pmid">24861842</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prince</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Dominger</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Cunha</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>NC</given-names>
</name>
</person-group>
<article-title><italic>Klebsiella pneumoniae</italic> pneumonia</article-title>
<source/>Heart Lung
          <year>1997</year>
<volume>26</volume>
<fpage>413</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/S0147-9563(97)90028-5</pub-id>
<pub-id pub-id-type="pmid">9315470</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ou</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans</article-title>
<source/>Am. J. Clin. Nutr.
          <year>2013</year>
<volume>98</volume>
<fpage>111</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.3945/ajcn.112.056689</pub-id>
<pub-id pub-id-type="pmid">23719549</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>K</given-names>
</name>
<name>
<surname>DeCoffe</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Molcan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>DL</given-names>
</name>
</person-group>
<article-title>Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease</article-title>
<source/>Nutrients
          <year>2012</year>
<volume>4</volume>
<fpage>1095</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="doi">10.3390/nu4081095</pub-id>
<pub-id pub-id-type="pmid">23016134</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>